Siemens Healthineers PFA-100 Instrument (US/CA)

Description

The PFA-100™ System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.

The PFA-100™ System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.

• Helps detect inherited, acquired and drug-induced platelet dysfunction
• Screening test for patients with impaired primary hemostasis, such as von Willebrand disease
• Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients
• Assesses the platelet dysfunction due to the effect of Aspirin
• Evaluates platelet dysfunction in children over 1 year of age
• Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia

Specifications

• Type: Hemostasis System
• Sample Type: Citrated Whole Blood
• Throughput: Single Test: Col/EPI or Col/ADP: 6 tests/hour; Duplicate Test: Col/EPI or Col/ADP: 10 tests/hour
• Operating System: High-shear force dynamic flow system

Safety and Handling

WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov